Lung cancer trials in China

In China 1143 Also abroad 2747

1,143 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy
Where
Guangzhou, Meizhou, Shantou, Shenzhen
Age
18 years and over
People
120
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07375316
Phase 1/2Taking people
A Study of JMT203 in Patients With Cancer Cachexia
Where
Zhejiang
Age
18 years and over
People
307
Run by
Shanghai JMT-Bio Inc.
See details and how to joinNCT06868849
No phaseTaking people
Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer
Where
Guangzhou
Age
18 years and over
People
65
Run by
Guangzhou Concord Cancer Center
See details and how to joinNCT07412327
Phase 3Not yet taking people in China
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
Where
Tianjin
Age
18 years to 75 years
People
450
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07601048
Phase 3Taking people
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Where
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Linyi, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Tianjin, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
180 worldwide
Run by
Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00
No phaseNot yet taking people in China
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
Where
Shanghai
Age
18 years to 80 years
People
400
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07595120
Phase 2Taking people
Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%
Where
Xi'an
Age
65 years and over
People
60
Run by
Tang-Du Hospital
See details and how to joinNCT07596121
No phaseNot yet taking people in China
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Where
Beijing, Shenzhen, Taiyuan
Age
1 year and over
People
300
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07596524
Phase 2Taking people
Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy
Where
Guangzhou
Age
18 years to 75 years
People
78
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06868836
Phase 1Not yet taking people in China
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Where
Shanghai
Age
18 years to 70 years
People
18
Run by
Beijing DCTY Biotech Co.,Ltd.
See details and how to joinNCT07014878
Phase 2Taking people
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
864
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT07309276
No phaseNot yet taking people in China
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
Where
Chengdu
Age
18 years and over
People
200
Run by
Sichuan Cancer Hospital and Research Institute
See details and how to joinNCT07590596
Phase 1/2Taking people
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
Where
Beijing
Age
18 years to 75 years
People
105
Run by
Gang Hou
See details and how to joinNCT07332858
No phaseTaking people
Multimodal AI-Guided Recovery Management After Lung Cancer Surgery
Where
Guangzhou
Age
18 years to 80 years
People
868
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07588737
No phaseNot yet taking people in China
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Where
Beijing
Age
18 years to 70 years
People
20
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07589101
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 2Taking people
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Where
Beijing
Age
18 years and over
People
220
Run by
Peking University People's Hospital
See details and how to joinNCT07586826
No phaseTaking people
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
Where
Shanghai
Age
18 years to 74 years
People
367
Run by
Shanghai University of Traditional Chinese Medicine
See details and how to joinNCT05834413
Phase 3Taking people
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Where
Shanghai
Age
18 years to 75 years
People
478
Run by
Shanghai Chest Hospital
See details and how to joinNCT06437977
Phase 2Taking people
A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer
Where
Chengdu, Guangzhou, Zhengzhou
Age
18 years to 75 years
People
45
Run by
Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT07444437
Phase 2Taking people
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
Where
Jinan
Age
18 years to 75 years
People
90
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07489716
Phase 1Not yet taking people in China
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
Where
Beijing
Age
18 years and over
People
192
Run by
Corregene Biotechnology Co., Ltd
See details and how to joinNCT07583316
Phase 2Taking people
Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
Where
Guangzhou
Age
18 years and over
People
90
Run by
Sun Yat-sen University
See details and how to joinNCT07583511
Phase 1Not yet taking people in China
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
Where
Shanghai
Age
18 years and over
People
186
Run by
Chipscreen Biosciences, Ltd.
See details and how to joinNCT07583771
Phase 2Taking people
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
Where
Guangzhou
Age
18 years to 75 years
People
110
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT05351788